Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 21, 2009; 15(7): 871-876
Published online Feb 21, 2009. doi: 10.3748/wjg.15.871
Table 1 Toxicities of oxaliplatin plus capecitabine in 64 cases of metastatic ESCC (n %)
Side effectsGrade
0IIIIIIIV
Nausea and vomiting31 (48.4)21 (32.8)12 (18.8)0 (0.0)0 (0.0)
Diarrhea32 (50.0)20 (31.3)12 (18.7)0 (0.0)0 (0.0)
Aspherinia44 (68.7)11 (17.2)9 (14.1)0 (0.0)0 (0.0)
Leukopoenia32 (50.0)20 (31.3)10 (15.6)2 (3.1)0 (0.0)
Thrombocytopenia46 (71.9)11 (17.2)7 (10.9)0 (0.0)0 (0.0)
Nerve toxicity40 (62.5)14 (21.9)9 (14.1)1 (1.5)0 (0.0)
Hand-foot syndrome40 (62.5)13 (20.3)11 (17.2)0 (0.0)0 (0.0)
Alopecia60 (93.8)4 (6.2)0 (0.0)0 (0.0)0 (0.0)
Mucositis of mouth39 (60.9)18 (28.1)7 (10.9)0 (0.0)0 (0.0)
Abnormal liver function56 (87.6)7 (10.9)1 (1.5)0 (0.0)0 (0.0)